Matches in Wikidata for { <http://www.wikidata.org/entity/Q90303270> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q90303270 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q90303270 description "article scientifique (publié 2019)" @default.
- Q90303270 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90303270 description "artigo científico (publicado na 2019)" @default.
- Q90303270 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q90303270 description "artículo científico publicado en 2019" @default.
- Q90303270 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q90303270 description "im Jahr 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90303270 description "scientific article published on 01 January 2019" @default.
- Q90303270 description "wetenschappelijk artikel" @default.
- Q90303270 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q90303270 description "научна статия" @default.
- Q90303270 name "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 name "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 name "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 type Item @default.
- Q90303270 label "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 label "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 label "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 prefLabel "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 prefLabel "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 prefLabel "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 P1433 Q90303270-06F78E4A-6CB2-49EC-B18D-4FDB56176570 @default.
- Q90303270 P1476 Q90303270-B39C754F-5C97-4D73-BDBB-BD2211DE774D @default.
- Q90303270 P2093 Q90303270-59254746-2492-4E06-ACA7-787B70D9B905 @default.
- Q90303270 P304 Q90303270-59EBF46C-DA3A-4F79-92FF-D93688AB96F2 @default.
- Q90303270 P31 Q90303270-A5641C9E-0C00-443A-9F9E-A074B6A02011 @default.
- Q90303270 P356 Q90303270-81F72DD2-AA1C-40E4-950D-3C8B865B46C5 @default.
- Q90303270 P433 Q90303270-76936946-25F8-4C07-96D8-8936B279C79E @default.
- Q90303270 P478 Q90303270-60399302-2E89-4361-A7E3-C4F1DEFD75B6 @default.
- Q90303270 P50 Q90303270-5C45F21B-0E69-414B-B0DB-CBB084E5F40E @default.
- Q90303270 P50 Q90303270-870C93FE-B0F9-4B70-AF69-7E4CFD11ECC7 @default.
- Q90303270 P577 Q90303270-25B40CD8-56DF-49FB-A8BF-01599D9B78E8 @default.
- Q90303270 P698 Q90303270-E405002D-7D71-4D72-A775-B8DEFB423B31 @default.
- Q90303270 P921 Q90303270-0959AF90-8AA3-44F3-A2F4-E98627B1390E @default.
- Q90303270 P356 JAMAONCOL.2018.5739 @default.
- Q90303270 P698 30520954 @default.
- Q90303270 P1433 Q22079683 @default.
- Q90303270 P1476 "Trastuzumab Therapy for 9 Weeks vs 1 Year for Human Epidermal Growth Factor 2-Positive Breast Cancer-Reply" @default.
- Q90303270 P2093 "Val Gebski" @default.
- Q90303270 P304 "118" @default.
- Q90303270 P31 Q13442814 @default.
- Q90303270 P356 "10.1001/JAMAONCOL.2018.5739" @default.
- Q90303270 P433 "1" @default.
- Q90303270 P478 "5" @default.
- Q90303270 P50 Q125317699 @default.
- Q90303270 P50 Q16299408 @default.
- Q90303270 P577 "2019-01-01T00:00:00Z" @default.
- Q90303270 P698 "30520954" @default.
- Q90303270 P921 Q412616 @default.